PHARMALINE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMALINE
Largest movements
- Cash -€186,526
down €186,526 (-67.5%), from €276,292 to €89,766
mainly Other debts (-€149,822) and Contributions, distributions and other (-€48,353)
- Other debts -€149,822
down €149,822 (-43.3%), from €346,078 to €196,256
- Trade debts -€30,676
down €30,676 (-20.5%), from €149,672 to €118,995
- Gross operating margin -€8,279
down €8,279 (-4.2%), from €198,540 to €190,260
- Staff costs +€7,388
up €7,388 (+6.4%), from €116,024 to €123,412
- Taxes -€4,273
down €4,273 (-20.3%), from €21,093 to €16,820
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €524,325 | €339,554 | -€184,771 | -35.2% |
| Formation expenses | 20 | €938 | - | -€938 | |
| Fixed assets | 21/28 | €9,626 | €9,315 | -€311 | -3.2% |
| Tangible fixed assets | 22/27 | €9,526 | €9,215 | -€311 | -3.3% |
| Plant, machinery and equipment | 23 | €7,629 | - | -€7,629 | |
| Furniture and vehicles | 24 | €1,897 | €1,006 | -€890 | -46.9% |
| Other tangible fixed assets | 26 | - | €8,209 | +€8,209 | |
| Financial fixed assets | 28 | €100 | €100 | = | 0.0% |
| Current assets | 29/58 | €513,762 | €330,239 | -€183,523 | -35.7% |
| Stocks and contracts in progress | 3 | €95,150 | €96,620 | +€1,470 | +1.5% |
| Stocks | 30/36 | €95,150 | €96,620 | +€1,470 | +1.5% |
| Amounts receivable within one year | 40/41 | €137,934 | €139,387 | +€1,453 | +1.1% |
| Trade receivables | 40 | €132,013 | €130,686 | -€1,327 | -1.0% |
| Other amounts receivable | 41 | €5,921 | €8,701 | +€2,781 | +47.0% |
| Cash at bank and in hand | 54/58 | €276,292 | €89,766 | -€186,526 | -67.5% |
| Deferred charges and accrued income | 490/1 | €4,385 | €4,465 | +€80 | +1.8% |
| Total equity and liabilities | 10/49 | €524,325 | €339,554 | -€184,771 | -35.2% |
| Equity | 10/15 | €6,388 | €6,388 | = | 0.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Revaluation surpluses | 12 | €188 | €188 | = | 0.0% |
| Amounts payable | 17/49 | €517,937 | €333,166 | -€184,771 | -35.7% |
| Amounts payable within one year | 42/48 | €517,937 | €333,166 | -€184,771 | -35.7% |
| Trade debts | 44 | €149,672 | €118,995 | -€30,676 | -20.5% |
| Suppliers | 440/4 | €149,672 | €118,995 | -€30,676 | -20.5% |
| Taxes, remuneration and social security | 45 | €22,187 | €17,914 | -€4,273 | -19.3% |
| Taxes | 450/3 | €5,883 | - | -€5,883 | |
| Remuneration and social security | 454/9 | €16,305 | €17,914 | +€1,610 | +9.9% |
| Other amounts payable | 47/48 | €346,078 | €196,256 | -€149,822 | -43.3% |
| Remuneration, social security and pensions | 62 | €116,024 | €123,412 | +€7,388 | +6.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,273 | €3,949 | +€1,676 | +73.7% |
| Other operating charges | 640/8 | €180 | €180 | = | 0.0% |
| Non-recurring operating charges | 66A | €91 | - | -€91 | |
| Gross operating margin | 9900 | €198,540 | €190,260 | -€8,279 | -4.2% |
| Operating profit (loss) | 9901 | €79,971 | €62,719 | -€17,252 | -21.6% |
| Financial income | 75/76B | €1,403 | €2,841 | +€1,438 | +102.5% |
| Recurring financial income | 75 | €1,403 | €2,841 | +€1,438 | +102.5% |
| Financial charges | 65/66B | €308 | €387 | +€79 | +25.7% |
| Recurring financial charges | 65 | €308 | €360 | +€52 | +16.8% |
| Non-recurring financial charges | 66B | - | €28 | +€28 | |
| Profit (loss) for the period before taxes | 9903 | €81,066 | €65,173 | -€15,893 | -19.6% |
| Income taxes | 67/77 | €21,093 | €16,820 | -€4,273 | -20.3% |
| Profit (loss) for the period | 9904 | €59,973 | €48,353 | -€11,620 | -19.4% |
| Profit (loss) for the period to be appropriated | 9905 | €59,973 | €48,353 | -€11,620 | -19.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.